‘The illicit sector has a turnover of at least 10% of the world’s pharmaceutical business’

Global pharma companies are looking to sell off their mature drugs, which are often sold in emerging markets where governments demand low prices.

According to data, by 2016 pharmaceutical spending in Africa is expected to reach $30-billion – driven by the continent’s increasing economic wealth.

Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic.